✦ LIBER ✦

Tolcapone, a Selective Catechol-O-Methyltransferase Inhibitor for Treatment of Parkinson's Disease

✍ Scribed by David R. P. Guay

Book ID: 115047545
Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 91 KB
Volume: 19
Category: Article
ISSN: 0277-0008
DOI: 10.1592/phco.19.1.6.30516

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Catechol-O-methyltransferase inhibitors

Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease

✍ John G Nutt 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 49 KB

Catechol-O-methyltransferase inhibitors

Catechol-O-methyltransferase inhibitors in Parkinson's disease

✍ J Harper; B Vieira 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 18 KB

Catechol-O-methyltransferase inhibitors

Catechol-O-methyltransferase inhibitors in Parkinson's disease

✍ Colm Henry; JA Wilson 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 54 KB

Catechol-O-methyltransferase inhibitors

Catechol-O-methyltransferase inhibitors in Parkinson's disease

✍ Tao Xie; Shu-Leong Ho; David Ramsden 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 46 KB

Catechol-O-methyltransferase inhibitors:

Catechol-O-methyltransferase inhibitors: Clinical potential in the treatment of Parkinson's disease

✍ Jasper Dingemanse 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 2 views

Substitution therapy with levodopa and a peripheral inhibitor of aromatic L-amino acid decarboxylase (AADC) is the cornerstone in the treatment of Parkinson's disease. Chronic therapy with levodopa, however, is associated with the occurrence of motor complications that are partially related to the p

New, Selective Catechol-O-Methyltransfer

New, Selective Catechol-O-Methyltransferase Inhibitors as Therapeutic Agents in Parkinson’s Disease

✍ Vincenzo Bonifati; Giuseppe Meco 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 405 KB